Day One Biopharmaceuticals, Inc.
DAWN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $125 | $231 | $85 | $284 |
| Short-Term Investments | $407 | $136 | $257 | $0 |
| Receivables | $14 | $0 | $0 | $0 |
| Inventory | $3 | $0 | $0 | $0 |
| Other Curr. Assets | $13 | $9 | $6 | $5 |
| Total Curr. Assets | $562 | $375 | $348 | $289 |
| Property Plant & Equip (Net) | $5 | $1 | $1 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $16 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $20 | $1 | $1 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $583 | $376 | $349 | $290 |
| Liabilities | – | – | – | – |
| Payables | $3 | $3 | $0 | $2 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $2 | $0 | $0 | $0 |
| Other Curr. Liab. | $69 | $27 | $16 | $7 |
| Total Curr. Liab. | $73 | $30 | $17 | $9 |
| LT Debt | $3 | $0 | $0 | $0 |
| Deferred Rev, NC | $3 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $0 | $0 | $0 |
| Total NC Liab. | $7 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $3 | $0 | $0 | $0 |
| Total Liabilities | $80 | $30 | $17 | $9 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$554 | -$459 | -$270 | -$127 |
| AOCI | $0 | $0 | -$0 | $0 |
| Other Equity | $1,057 | $805 | $602 | $409 |
| Total Equity | $503 | $347 | $332 | $281 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $583 | $376 | $349 | $290 |
| Net Debt | -$122 | -$230 | -$84 | -$284 |